Silence Therapeutics’ (SLN) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note issued to investors on Friday,Benzinga reports. HC Wainwright currently has a $75.00 price objective on the stock. A number of other research analysts have also issued reports on the stock. BMO Capital Markets lowered their target […]
HC Wainwright reissued their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note issued to investors on Friday,Benzinga reports. HC Wainwright currently has a $75.00 price objective on the stock. A number of other research analysts have also issued reports on the stock. BMO Capital Markets lowered their target […]
